Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Banks, capital goods boost indices
Thu, 17 Feb 01:30 pm

Indian indices continued to gain momentum as buying interest in heavy weights intensified during the previous two hours of trade. Stocks from the capital goods and banking space are currently leading the gains, while stocks from the realty space are trading weak.

The BSE-Sensex is up by 175 points while NSE-Nifty is trading 56 points above the dotted line. BSE Midcap index is up by 0.89% while BSE Small cap index is trading 1.07% above yesterday's closing. The rupee is trading at 45.36 to the US dollar.

After continuous rise in oil, commodity and food prices we now have a sign of relief. Government data show food inflation eased to 11.05% for the week ended Feb 5, 2011 as compared to 13.07% in the previous week. This is the lowest reading in the previous two months. It was the low agricultural productivity that had fueled the food inflation. The primary articles index rose by 14.59% in comparison to the rise of 17.05% a week earlier. The Prime Minister on Wednesday said that headline inflation will come to no more than 7% by March-end. And latest inflation numbers suggest we are headed in the right direction.                                                              

Pharma stocks are trading mixed with Dr Reddy's, Elder Pharma and J B Chemicals trading firm, while Aurobindo Pharma, Orchid Chemicals and Cipla are trading in the red. Glenmark Pharmaceuticals has announced that its novel molecule for pain and respiratory problems is entering human trials. The molecule has successfully completed pre-clinical trials and has been filed for human trials in Europe. The company said the addressable market for the drug is around US $30 bn while the market for osteoarthritis and neuropathic pain in around US $10 bn. This development gives better visibility into the long term revenue stream for the company.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Banks, capital goods boost indices". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.